Integra IT's
History
Integra IT over the years

- e-Diary used in 2 Polio studies in Colombia and Panama
- The surveillance "Vigilant-e" App was developed
- The e-CRF was developed.
- The site CTMS Patient Follow up System was developed.
- First Dengue study DEN 204 with 950 subjects.
-
IPV001 and IPV002 Polio studies used our CRF
in Panama, Colombia, Chile, Dominican
Republic and Guatemala.
2014
- Integra IT consolidation.
-
Fist eDiary version is launched.
2012-2013

- The PFS and the Vigilant-e were used in Panama for surveillance in a Dengue study.
- First norovirus and meningococcus studies.

Integra IT over the years

- LARIX and SSI Audited Integra IT.
- Our first study in Europe in a Polio study in Lithuania.
2016
2015
- PICRIS Audited Integra IT
- IT Brand Certified.
- An article about "Performance of a Mobile Phone App-Based Participatory Syndromic Surveillance System for Acute Febrile Illness and Acute Gastroenteritis in Rural Guatemala" related to our Vigilant-e app was published.
-
The "Study Tracking System" CTMS for CROs
st version was re eased.

Integra IT over the years

- The PFS II, with a brand new interface, and the Trial Pal (mobile app with the features of the Vigilant-e and e-Diary) were released.
2018
2017
- Integra IT started supporting Real World Evidence (RWE) studies.
- The "RESEGIS" software for health investigations tracking was developed for the Panamanian Ministry of Health.
Integra IT over the years

- Two pentest satisfactory analyses
- HIPAA assessment
- ISO27001 journey continues.
- First site network supported in the USA.
First Norovirus clinical trial in Latam and USA.
• A 98% adherence rate reached in a flu trial.
• Data Management and Biostatistics services consollcation.
• Agreement with SURA site network for Trial360
2020
2019
- The fight against COVID-19 continued with two more projects. Integra IT became part of Medidata RAVE partner central, and Integration between systems was developed. Vaxtrials Audited Integra IT.Trial 360 ERP for sites with electronic health records validated for clinical trials 1st implementation in colombia.TrialPal version 2 with eConsent release date: October 2021.

Integra IT over the years

- Two pentest satisfactory analyses
- HIPAA assessment
- ISO27001 journey continues.
- First site network supported in the USA.
First Norovirus clinical trial in Latam and USA.
• A 98% adherence rate reached in a flu trial.
• Data Management and Biostatistics services consollcation.
• Agreement with SURA site network for Trial360
2022
2021
- Syneos Health Partnership for Vaccines.
- Viedoc Partnership for Latin America.
- 1st time as Clinical Research Insider Sponsor in Mexico
- Trial360 expansion through Latin America
including new countries like Mexico, Argentina
& Dominican Republic

Integra IT over the years

- The best is yet to come...
Join Us!
20XX
2023
Our Experience
Nuestra Experiencia
Enfermedades
COVID-19
Chikunguña
Polio
Dengue
Herpes Zoster
Pertussis
Hepatitis A
Norovirus
Meningococo
Rotavirus
RSV
Diabetes
Fabry
Angioedema hereditario
Asma (RWE)
Cáncer de próstata (RWE)
Gripa
Cáncer de mama (RWE)
Trastorno de excitación sexual
Centros de Investigación
Mar de Plata Site
Cevaxin
Christus
Clinica del Contry
Policlínico Social del Norte
INVERIME
Probebe
Resegis
IM CER
Scientia Site
SolidRiver ERP
Ceclisa
CEIP
Kohler & Milstein
IP Fusa
MRX
TrialsFe
CROs
VaxTrials
JSS Research
PPD
ASSIGN
P95
Patrocinadores
AstraZeneca
OPS
Takeda
Bill & Melinda Gates Foundation
FIDEC
GSK
University of Colorado
AJ Vaccines
CureVac
Oxford University
Shire
Clover
Valneva
Hillevax
Medigen
Otros Clientes
Afidro
MINSA Panama
Botucatu City
Nuestras Ubicaciones
Colombia
Estados Unidos
Chile
Panamá
República Dominicana
Lituania
Guatemala
Alemania
Turquía
Perú
Brasil
Golfo Pérsico
Arabia Saudita
India
Argentina
Filipinas
Tailandia
Paraguay
Honduras
Puerto Rico
México
Nuestra Experiencia
Enfermedades
COVID-19
Chikunguña
Polio
Dengue
Herpes Zoster
Pertussis
Hepatitis A
Norovirus
Meningococo
Rotavirus
RSV
Diabetes
Fabry
Angioedema hereditario
Asma (RWE)
Cáncer de próstata (RWE)
Gripa
Cáncer de mama (RWE)
Trastorno de excitación sexual
Centros de Investigación
Mar de Plata Site
Cevaxin
Christus
Clinica del Contry
Policlínico Social del Norte
INVERIME
Probebe
Resegis
IM CER
Scientia Site
SolidRiver ERP
Ceclisa
CEIP
Kohler & Milstein
IP Fusa
MRX
TrialsFe
CROs
VaxTrials
JSS Research
PPD
ASSIGN
P95
Patrocinadores
AstraZeneca
OPS
Takeda
Bill & Melinda Gates Foundation
FIDEC
GSK
University of Colorado
AJ Vaccines
CureVac
Oxford University
Shire
Clover
Valneva
Hillevax
Medigen
Otros Clientes
Afidro
MINSA Panama
Botucatu City
Nuestras Ubicaciones
Colombia
Estados Unidos
Chile
Panamá
República Dominicana
Lituania
Guatemala
Alemania
Turquía
Perú
Brasil
Golfo Pérsico
Arabia Saudita
India
Argentina
Filipinas
Tailandia
Paraguay
Honduras
Puerto Rico
México